Table of Contents Table of Contents
Previous Page  482-483 / 1152 Next Page
Information
Show Menu
Previous Page 482-483 / 1152 Next Page
Page Background

Clinical gain from RT research

Delta outcome

Increase in TCP or OS

Decrease in toxicity

Delta patients

Eligibility of new patient groups for RT

Increase in number of patients in a patient group

Delta XX

Derivative effects of developments (such as new

technologies useful for wider scope of applications)